Connect your AI

Alpha Cognition ACOG 2029

2029 at other companies

BiogenBIIB

——

ANI PharmaceuticalsANIP

——

Other financials

Income statement

Revenue$3.5M+20.7%

Gross profit$3.3M+12.7%

Operating income-$8.1M-138%

Net income-$6.5M-276%

EPS (diluted)-$0.32-191%

Balance sheet

Cash & equivalents$54.3M+100,638%

Total equity$57.5M+49.2%

Total assets$69.2M+42.5%

Cash flow

Operating cash flow-$11.8M-477%

CapEx$1.3K-97.9%

Free cash flow-$11.8M-460%

Valuation

Market cap$157.21M+6.6%

P/S14.5×—

Profitability

Gross margin89.3%—

Operating margin-250.1%—

Net margin-232.2%—

FCF margin-280.5%—

Returns & leverage

Return on equity-52.4%-5.3pp

Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Alpha Cognition's 2029?: Alpha Cognition (ACOG) reported 2029 of $21.55K in Q1 2026.
How has Alpha Cognition's 2029 changed year-over-year?: Alpha Cognition's 2029 decreased by 0.0% year-over-year, from $21.55K to $21.55K.